Why I’d buy GSK shares despite the coming dividend cut

GlaxoSmithKline intends to split itself up and reduce its dividends. G A Chester explains why he thinks now is a good time for him to buy GSK shares.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Owning GlaxoSmithKline (LSE: GSK) shares has been somewhat disappointing for many long-term investors. And with a dividend cut looming, some have decided it’s time to sell up.

However, despite the underwhelming past performance, I personally think the future could be a lot brighter. Indeed, I reckon now could be an opportune time for me to buy the stock. Here, I’ll explain my thinking.

Poor performance of GSK shares

It’s a sad fact that GSK’s all-time-high share price (over £23) was as long ago as January 1999. This was almost two years before the Glaxo Wellcome/SmithKline Beecham merger that formed the platform of the group we know today. The share price hasn’t come near £23 in the 21st century. And I can currently buy the shares for little more than £14.

Should you invest £1,000 in Ashtead Group Plc right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Ashtead Group Plc made the list?

See the 6 stocks

Returns for investors over the last five and 10 years have been inferior to the FTSE 100. On an annualised basis, 5.6% versus 7.2% (over five years) and 5.7% versus 6% (over 10 years). These returns include dividends. And as GSK’s annual payout has been stuck at 80p a share since 2014, investors who bought for income have seen their spending power nibbled away each year by inflation.

This may not seem a promising backdrop for me to buy GSK’s shares today. But as I mentioned, I think the future could be a lot brighter, despite the coming dividend cut.

GSK and GSK Consumer Healthcare shares

GSK is planning to split itself into two companies next year, and the dividend cut will accompany this. Many analysts and institutional shareholders have long felt the market is applying a ‘conglomerate discount’ to GSK. In other words, that its pharmaceuticals, vaccines and consumer healthcare businesses would be valued more highly by the market if they were standalone companies.

By buying GSK shares today, I could benefit from an uplift if the group’s demerger of its consumer healthcare business unlocks value. Of course, there’s no guarantee the aggregate value of the shares I would hold in the two companies would be higher than today’s £14. Indeed, there’s a risk it could be lower. The market could respond unfavourably when it gets more detail on the new corporate structures and dividend policies of the standalone companies.

GSK will be providing an investor update for shareholders on Wednesday (23 June). This is to outline strategy, growth outlooks (2022-2031), capital allocation priorities and timing and approach to separation.” The unveiling of its dividend plans is also on the agenda.

Dividends

GSK has already said it expects the aggregate dividend of the two companies to be less than the current 80p. In an article back in February, my Motley Fool colleague Cliff D’Arcy noted analysts were forecasting 67p (a 16% reduction).

Today, the company-compiled consensus on GSK’s website is 54.6p (a 32% reduction), giving a yield of 3.8% on the current share price. Of course, the analyst consensus could prove to be too optimistic or too pessimistic. As such, there’s a risk I could be in for a lower dividend.

Still, despite the current areas of uncertainty and risks I’ve mentioned, I’d be happy to buy GSK shares today. Ultimately, I think the separation will unlock value. And that the standalone businesses can thrive with energised and focused management.

Should you invest £1,000 in Ashtead Group Plc right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.

And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Ashtead Group Plc made the list?

See the 6 stocks

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any of the shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Array of piggy banks in saturated colours on high colour contrast background
Dividend Shares

A 9.16% yield! Here’s the eye-catching dividend forecast for this hotshot

Jon Smith eyes up a juicy dividend forecast for a renewable energy stock that has a dividend policy aiming to…

Read more »

Rear view image depicting a senior man in his 70s sitting on a bench leading down to the iconic Seven Sisters cliffs on the coastline of East Sussex, UK. The man is wearing casual clothing - blue denim jeans, a red checked shirt, navy blue gilet. The man is having a rest from hiking and his hiking pole is leaning up against the bench.
Investing Articles

Up 30% in 2025, can the Prudential share price keep climbing?

After a few years in the doldrums, Andrew Mackie explains why he believes momentum could push the Prudential share price…

Read more »

Workers at Whiting refinery, US
Investing Articles

I’m pinning my hopes on this activist investor kickstarting the BP share price

Elliott Investment Management reckons the BP share price doesn’t reflect the true potential of the energy giant. Our writer takes…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

Here’s a Warren Buffett share I’m considering adding to my portfolio!

Of the dozens of businesses Berkshire Hathaway has interests in, this is the Warren Buffett beauty I'm looking to buy…

Read more »

Happy woman commuting on a train and checking her mobile phone while using headphones
Investing Articles

7% and 13.4% dividend yields! 2 investment trusts to consider for a second income

Considering some dividend-paying investment trusts could be a great way to make a start on sourcing a second income in…

Read more »

Smiling white woman holding iPhone with Airpods in ear
Investing Articles

275 shares to consider for a 9.64% Stocks & Shares ISA return!

Looking for ways to boost a Stocks and Shares ISA? Here's a top investment trust that's delivered huge returns since…

Read more »

Close-up image depicting a woman in her 70s taking British bank notes from her colourful leather wallet.
Investing Articles

£10,000 invested in NatWest shares 5 years ago is now worth…

NatWest shares have surged over the past five years, rewarding investors as if it were some sort of revolutionary artificial…

Read more »

Young Asian man drinking coffee at home and looking at his phone
Investing Articles

Does the GSK or AstraZeneca share price currently offer the best value?

The AstraZeneca share price has pulled back in recent months. Dr James Fox explores how the stock compares with pharma…

Read more »